IgA vasculitis: Etiology, treatment, biomarkers and epigenetic changes

34Citations
Citations of this article
108Readers
Mendeley users who have this article in their library.

Abstract

IgA, previously called Henoch-Schönlein vasculitis, is an essential immune component that drives the host immune response to the external environment. As IgA has the unique character-istic of a flexible response to broad types of microorganisms, it sometimes causes an autoreactive response in the host human body. IgA vasculitis and related organ dysfunction are representative IgA-mediated autoimmune diseases; bacterial and viral infections often trigger IgA vasculitis. Recent drug developments and the presence of COVID-19 have revealed that these agents can also trigger IgA vasculitis. These findings provide a novel understanding of the pathogenesis of IgA vasculitis. In this review, we focus on the characteristics of IgA and symptoms of IgA vasculitis and other organ dysfunction. We also mention the therapeutic approach, biomarkers, novel triggers for IgA vasculitis, and epigenetic modifications in patients with IgA vasculitis.

Cite

CITATION STYLE

APA

Sugino, H., Sawada, Y., & Nakamura, M. (2021). IgA vasculitis: Etiology, treatment, biomarkers and epigenetic changes. International Journal of Molecular Sciences, 22(14). https://doi.org/10.3390/ijms22147538

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free